Receptor Activator of NF-κB (RANK) Confers Resistance to Chemotherapy in AML and Associates with Dismal Disease Course

SIMPLE SUMMARY: Acute myeloid leukemia (AML) is the most common form of acute leukemia in adults. Despite the emergence of new therapeutic agents in recent years, curation remains challenging, and new and better treatment options are needed. In the present study, we investigated the expression, prog...

Descripción completa

Detalles Bibliográficos
Autores principales: Clar, Kim L., Weber, Lisa M., Schmied, Bastian J., Heitmann, Jonas S., Marconato, Maddalena, Tandler, Claudia, Schneider, Pascal, Salih, Helmut R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8657109/
https://www.ncbi.nlm.nih.gov/pubmed/34885231
http://dx.doi.org/10.3390/cancers13236122

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8657109/
https://www.ncbi.nlm.nih.gov/pubmed/34885231
http://dx.doi.org/10.3390/cancers13236122

Ejemplares similares